Warner-Lambert/Parke Davis award lecture: Mechanisms of apoptosis

American Journal of Pathology

Volumn 157, Issue 5, 2000, Pages 1415-1430

  Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CASPASE; PROTEIN BCL 2; BACTERIAL PROTEIN; CARD PROTEIN, MYXOCOCCUS XANTHUS; INHIBITOR OF APOPTOSIS PROTEIN; INSECT PROTEIN; PROTEIN; TRANSACTIVATOR PROTEIN;

APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; ENZYME MECHANISM; FETUS; FETUS DEVELOPMENT; HUMAN; HUMAN CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; REGULATORY MECHANISM; REVIEW; ANIMAL; ARTICLE; ENZYME ACTIVATION; GENETICS; MULTIGENE FAMILY; PHYSIOLOGY; PROTO ONCOGENE;

ANIMALS; APOPTOSIS; BACTERIAL PROTEINS; CASPASES; ENZYME ACTIVATION; GENES, BCL-2; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; INSECT PROTEINS; MULTIGENE FAMILY; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANS-ACTIVATORS;

EID: 0034320568     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9440(10)64779-7     Document Type: Review

References (212)

1. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
2. Human ICE/CED-3 protease nomenclature
3. Caspases: Enemies within
4. Proteases to die for
5. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis
6. Caspases and cytokines: Roles in inflammation and autoimmunity
7. Caspases: Intracellufar signaling by proteolysis
8. A combinatorial approach defines specificities of members of the caspase family and granzyme B
9. Caspase activation: The induced-proximity model
10. Tumor necrosis factor receptor and Fas signaling mechanisms
11. Transducing signals of life and death
12. Cytochrome c; can't live with it; can't live without it
13. Mitochondria and apoptosis
14. Targeted disruption of the mouse caspase 8 gene ablates celt death inducation by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally
15. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade
16. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
17. Differential requirement for caspase 9 in apoptotic pathways in vivo
18. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
19. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain
20. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
21. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
22. An induced proximity model for caspase-8 activation
23. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3
24. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9
25. Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation
26. Cytochrome c and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade
27. Pro-caspase-3 is a major physiologic target of caspase-8
28. Dark is a Drosophila homologue of Apaf-1/CED-4 and functions in an evolutionarily conserved death pathway
29. NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain
30. NMR structure of the death domain of the p75 neurotrophin receptor
31. P75NTR and the concept of cellular dependence: Seeing how the other half die
32. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappaB activation
33. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95
34. Identification and functional characterization of DR6, a novel death domain-containing TNF receptor
35. FADD essential for embryo development and signaling from some, but not all, inducers of apoptosis
36. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort 1
37. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
38. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5
39. RAIDD is a new 'death' adaptor molecule
40. CRADD, a novel human apoptotic adaptor molecule for caspase-2 and FasL/tumor necrosis factor receptor-interacting protein RIP
41. Death associated proteins (DAPs): From gene identification to the analysis of their apoptotic and tumor suppressive functions
42. Evidence for a function of death-receptor-related, deathdomain-containing proteins in anoikis
43. Involvement of FADD and caspase-8 signaling in detachment-induced apoptosis
44. Integrins and anoikis
45. RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death
46. Goeddel DV; TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex
47. RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis
48. NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes
49. Overexpression of A1: An NF-κB-inducible, anti-apoptotic Bcl gene that inhibits endothelial cell activation
50. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis
51. Nuclear factor (NF)-κB-regulated X-chromosome-linked lap gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis
52. Cytokine induced expression of porcine inhibitor of apoptosis protein (iap) family member is regulated by NF-κB
53. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress capase-8 activation
54. Suppression of TNF-α-induced apoptosis by NF-κB
55. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death
56. Interleukin 1β converting enzyme-like proteases are essential for p53-mediated transcriptionally dependent apoptosis
57. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains
58. An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators
59. Apoptosis: Silencing the death receptors
60. FAP-1: A protein tyrosine phosphatase that associates with Fas
61. Functional interaction of Fas-associated phosphatase-1 (FAP-1) with p75 and their effect on NF-kB activation
62. The molecular interaction of Fas and FAP-1: A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis
63. Characterization of FAP-1 expression and function in throid follicular cells
64. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes
65. Apoptosis in AIDS
66. Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
67. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
68. Activation-induced apoptosis in lymphoid systems
69. Molecules involved in cell death and peripheral tolerance
70. Mutations in the Fas antigen in patients with multiple myeloma
71. Protection from fas-mediated apoptosis by a soluble form of the fas molecule
72. Opposing effects of transmembrane and soluble fas ligand expression on inflammation and tumor cell survival
73. Apoptosis control by death and decoy receptors
74. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
75. TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling
76. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
77. How TRAIL kills cancer cells, but not normal cells
78. Steering anti-cancer drugs away from the TRAIL
79. On the TRAIL from p53 to apoptosis?
80. NMR structure and mutagenesis of the FADD (Mort1) death-effector domain
81. DEDD, a novel death effector domain-containing protein, targeted to the nucleolus
82. DEFT, a novel death effector domain-containing molecule predominantly expressed in testicular germ cells
83. Placing death under control
84. Inhibition of Fas death signals by Flips
85. Inhibition of death receptor signaling by FLICE-inhibitory protein as a mechanism for immune escape of tumors
86. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
87. The Fas counterattack in vivo: Apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma
88. Fas ligand expression in primary colon adenocarcinomas: Evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer
89. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
90. The fight of viruses against apoptosiscurr
91. Death effector domain-containing herpesvirus and poxvirus proteins inhibit Fas- and TNFR1-induced apoptosis
92. Bovine herpesvirus 4 BORFE2 protein inhibits Fas- and TNFR1-induced apoptosis and contains death effector domains shared with other gamma 2 herpesviruses
93. p28 Bap31, a Bcl-2/Bcl-X(L)- and procaspase-8-associated protein in the endoplasmic reticulum
94. BAR: An apoptosis regulator at the intersection of caspase and bcl-2 family proteins
95. Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex
96. Mice deficient in IL-1βconverting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock
97. Defects in regulation of apoptosis in caspase-2-deficient mice
98. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE
99. Sealing one's fate: Control of cell death in neurons
100. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
101. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
102. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment
103. Solution structure of Apaf-1 CARD and its interation with caspase-9 CARD: A structural basis for specific adaptor/caspase interaction
104. Crystal structure of Apaf-1 caspase recruitment domain: A alpha-helical Greek key fold for apoptotic signaling
105. Solution structure and mutagenesis of the caspase recruitment domain (CARD) from Apaf-1
106. The NACHT family: A new group of predicted NTPases implicated in apoptosis and MHC transcription activation
107. Role of CED-4 in the activation of CED-3
108. Caenorhabditis elegans CED-4 stimulates CED-3 processing and CED-3-induced apoptosis
109. Essential role of CED-4 oligomerization in CED-3 activation and apoptosis
110. An emerging blueprint for apoptosis in drosophila
111. Identification of an endogenous dominantnegative short isoform of caspase-9 that can regulate apoptosis
112. Regulation of cell death protease caspase-9 by phosphorylation
113. Negative regulation of cytochrome c-mediated oligomerization of apaf-1 and activation of proeaspase-9 by heat shock protein 90β
114. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome
115. Changes in intramitochondrial and cytosolic pH: Early events that modulate caspase activation during apoptosis
116. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kB
117. Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-κB
118. Apaf1 is required for mitochondrial pathways of apoptosis and brain development
119. Bcl10 is involved in t(1;14) (p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types
120. CIPER, a novel NF kappaB-activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein E10
121. mE10, a novel caspase recruitment domain-containing proapoptotic molecule
122. Inactivating mutations and overexpression of BCL-10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)
123. Point mutations and deletions of the Bcl-10 gene in solid tumors and malignant lymphomas
124. RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis
125. Identification of CARDIAK, a RIP-like kinase that assciares with caspase-1
126. RIP2 is a novel NF-κB-activating and cell death-inducing kinase
127. Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkB
128. IAP family proteins: Suppressors of apoptosis
129. The inhibitors of apoptosis (IAPs) and their emerging role in cancer
130. An exegesis of IAPs: Salvation and surprises from BIR motifs
131. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP
132. Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat
133. Structure of the Human anti-apoptotic protein survivin reveals a dimeric arrangement
134. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli
135. A giant ubiquitinconjugating enzyme related to lAP apoptosis inhibitors
136. A human IAP family gene, apollon, expressed in human brain cancer cells
137. Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis
138. Role for yeast inhibitor of apoptosis (IAP)-like proteins in cell division
139. X-linked IAP is a direct inhibitor of cell death proteases
140. The c-IAP-1 and c-IaP-2 proteins are direct inhibitors of specific caspases
141. Cleavage of human inhibitor of apoptosis protein xiap results in fragments with distinct specificities for caspases
142. A single BIR domain of XIAP sufficient for inhibiting caspases
143. Interaction of the baculovirus antiapoptotic protein p35 with capases: Specificity, kinetics, and characterization of the caspase/p35 complex
144. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases
145. Evolutionary conservation of apoptosis mechanisms: Lepidopteran and baculoviral inhibitor of apoptosis proteins are inhibitors of mammalian caspase-9
146. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy
147. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
148. Developmentally regulated expression of the novel cancer antiapoptosis gene survivin in human and mouse differentiation
149. Analysis of human transcriptomes
150. Control of apoptosis and mitotic spindle checkpoint by survivin
151. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function
152. Cell division regulation by BIR1, a member of the inhibitor of apoptosis family in yeast
153. Expression and prognostic significance of iap family genes in human cancers and myeloid leukemias
154. Mechanisms and genes of cellular suicide
155. Inhibitor of apoptosis proteins physically interact with and block apoptosis induced by Drosophila proteins HID and GRIM
156. The drosophila caspase inhibitor diap 1 is essential for cell survival and is negatively regulated by hid
157. Doom, a product of the Drosophila mod(md94) gene, induces apoptosis and binds to baculovirus inhibitor-of-apoptosis proteins
158. Induction of apoptosis by Drosophila reaper, hid and grim through inhibition of IAP function
159. Drosophila p53: Meeting the grim reaper
160. The proapoptotic function of Drosophila Hid is conserved in mammalian cells
161. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
162. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins
163. Scythe: A novel reaper-binding apoptotic regulator
164. Double identity for proteins of the Bcl-2 family
165. The Bcl-2 protein family: Arbiters of cell survival
166. Bcl-2 family proteins
167. BCL-2 family members and the mitochondria in apoptosis
168. Bcl-2 family proteins: The role of the BH3 domain in apoptosis
169. Mechanisms of Bcl-2 family protein function and dysfunction in health and disease
170. Involvement of the Bcl-2 gene in human follicular lymphoma
171. Molecular analysis of the t(14; 18) chromosomal translocation in malignant lymphomas
172. Bcl-2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy
173. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype
174. Bax suppresses tumorigenesis and stimulates apoptosis in vivo
175. Tumor suppressor p53 is a direct transcriptional activator of human Bax gene
176. Upregulation of Bax protein levels in neurons following cerebral ischemia
177. BAX is required for neuronal death after trophic factor deprivation and during development
178. Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death
179. Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimers disease hippocampus
180. bcl-2 Overexpression reduces apoptotic photoreceptor cell death in three different retinal degenerations
181. Bax promotes neuronal survival and antagonises the survival effects of neurotrophic factors
182. Boo, a novel negative regulator of cell death, interacts with Apaf-1
183. Diva, a Bcl-2 homologue that binds directly to Apaf-1 and induces BH3-independent cell death
184. X-ray and NMR structure of human Bcl-XL, an inhibitor of programmed cell death
185. Solution structure of BID, an intracellular amplifier of apoptotic signaling
186. Solution structure of the proapoptotic molecule BID: A structural basis for apoptotic agonists and antagonists
187. Bcl-2 family proteins as ion-channels
188. BCl-x(L) forms an ion channel in synthetic lipid membranes
189. Channel formation by antiapoptotic protein Bcl-2
190. Inhibition of Bax channelforming activity by Bcl-2
191. Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2
192. Ion channel activity of the BH3 only Bcl-2 family member, BID
193. Structure of Bcl-xL-Bak peptide complex: Recognition between regulators of apoptosis
194. The E1B 19K/Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis
195. BID: A novel BH3 domain-only death agonist
196. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c depletion during apoptosis
197. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
198. Bid, a Bol2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
199. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
200. The proapoptotio activity of the Bcl-2 family member bim is regulated by interaction with the dynein motor complex
201. A bad kinase makes good
202. Cellular survival: A play in three Akts
203. Calcineurin promotes apoptosis by dephosphorylating BAD
204. Conformation of the Bax Coterminus regulates subcellular location and cell death
205. Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH
206. Mitochondrial control of cell death
207. The caspase-3 precursor has a cytosolic and mitochondrial distribution: Implications for apoptotic signaling
208. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebrar ischemia
209. Mitochondrial release of caspases-2 and -9 during the apoptotic process
210. Molecular characterisation of mitochondrial apoptosis-inducing factor (AIF)
211. Apoptosis-based therapeutics: From bench to clinic, how far have we come?